Virtus Biotech Etf (BBP) is an ETF managed by Independent / Boutique. Its largest position is ImmunityBio, Inc. (IBRX), representing 4.80% of fund assets.
Virtus Biotech Etf Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BBP
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 22, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ImmunityBio, Inc.
|
4.80% | $2,847,135.50 | 401,005 |
|
-
DREYFUS GOVERNMENT CASH MANAGEMENT
|
3.15% | $1,868,133.71 | 1,868,134 |
|
-
APELLIS PHARMACEUTICALS INC
|
2.59% | $1,535,993.55 | 37,509 |
|
-
KALVISTA PHARMACEUTICALS INC
|
2.52% | $1,492,000.24 | 55,964 |
|
-
Moderna, Inc.
|
2.49% | $1,475,684.68 | 32,122 |
|
-
IOVANCE BIOTHERAPEUTICS, INC.
|
2.44% | $1,445,361.12 | 430,167 |
|
-
Mirum Pharmaceuticals, Inc.
|
2.39% | $1,416,638.98 | 14,558 |
|
-
Axsome Therapeutics, Inc.
|
2.24% | $1,326,691.50 | 6,386 |
|
-
Kiniksa Pharmaceuticals International, plc
|
2.06% | $1,223,710.12 | 22,754 |
|
-
Roivant Sciences Ltd.
|
2.06% | $1,221,683.13 | 42,821 |
|
-
Zai Lab Ltd
|
1.94% | $1,152,459.84 | 53,256 |
|
-
LIGAND PHARMACEUTICALS INC
|
1.93% | $1,145,414.40 | 4,992 |
|
-
BIOCRYST PHARMACEUTICALS INC
|
1.93% | $1,145,137.40 | 125,015 |
|
-
Travere Therapeutics, Inc.
|
1.93% | $1,144,400.40 | 27,170 |
|
-
NOVAVAX INC
|
1.93% | $1,141,548.70 | 144,044 |
|
-
UNITED THERAPEUTICS Corp
|
1.84% | $1,093,563.90 | 1,914 |
|
-
GERON CORP
|
1.81% | $1,071,625.94 | 695,861 |
|
-
BioNTech SE
|
1.74% | $1,032,534.45 | 9,981 |
|
-
AMGEN INC
|
1.74% | $1,030,786.25 | 2,977 |
|
-
EXELIXIS, INC.
|
1.74% | $1,029,160.08 | 23,148 |
|
-
BIOGEN INC.
|
1.73% | $1,028,547.52 | 5,434 |
|
-
GILEAD SCIENCES, INC.
|
1.73% | $1,028,271.56 | 7,859 |
|
-
TG THERAPEUTICS, INC.
|
1.72% | $1,019,716.86 | 30,187 |
|
-
Krystal Biotech, Inc.
|
1.71% | $1,013,897.16 | 3,866 |
|
-
Legend Biotech Corp
|
1.68% | $997,200.96 | 42,398 |
|
-
Syndax Pharmaceuticals Inc
|
1.68% | $995,573.51 | 46,457 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.67% | $992,053.48 | 13,501 |
|
-
Ascendis Pharma A/S
|
1.66% | $984,728.34 | 4,293 |
|
-
AGIOS PHARMACEUTICALS, INC.
|
1.64% | $971,684.00 | 34,703 |
|
-
HALOZYME THERAPEUTICS, INC.
|
1.63% | $968,332.26 | 15,211 |
|
-
ARDELYX, INC.
|
1.63% | $964,647.69 | 152,393 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.61% | $956,902.50 | 17,750 |
|
-
INCYTE CORP
|
1.59% | $944,887.86 | 9,918 |
|
-
Aurinia Pharmaceuticals Inc.
|
1.55% | $918,592.20 | 59,707 |
|
-
Sarepta Therapeutics, Inc.
|
1.55% | $917,780.40 | 43,955 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.52% | $902,208.56 | 1,276 |
|
-
BridgeBio Pharma, Inc.
|
1.51% | $895,417.12 | 12,592 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.51% | $894,506.34 | 2,093 |
|
-
BeOne Medicines Ltd.
|
1.48% | $875,475.55 | 2,965 |
|
-
IONIS PHARMACEUTICALS INC
|
1.48% | $875,290.08 | 11,708 |
|
-
CRISPR Therapeutics AG
|
1.47% | $873,816.30 | 16,695 |
|
-
Theravance Biopharma, Inc.
|
1.47% | $871,852.68 | 52,082 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
1.44% | $856,280.45 | 1,655 |
|
-
Kura Oncology, Inc.
|
1.38% | $817,649.17 | 92,599 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.38% | $815,300.64 | 6,192 |
|
-
PTC THERAPEUTICS, INC.
|
1.37% | $813,900.60 | 12,510 |
|
-
ACADIA PHARMACEUTICALS INC
|
1.32% | $782,494.75 | 34,855 |
|
-
Arcutis Biotherapeutics, Inc.
|
1.28% | $757,204.20 | 32,610 |
|
-
Tarsus Pharmaceuticals, Inc.
|
1.25% | $739,911.52 | 11,632 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.24% | $736,276.71 | 2,379 |
Advertisement (320x50)